Chemomab Therapeutics Ltd.
CMMB- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001534248
In the last 90 days, Chemomab Therapeutics Ltd. insiders filed 0 open-market purchases and 1 sale; 13 institutions reported holding it in 13F filings for Q2 2026, worth $615.3K in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Chemomab Therapeutics Ltd. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Q3 2024 | Change |
|---|---|---|---|
| Holders | 15 | 15 | 0 |
| Shares | 2.67M | 4.55M | +1.88M (+70.2%) |
| Value | $2.44M | $7.14M | +$4.70M (+192.6%) |
New holders (6)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Sphera Funds Management Ltd. | 1,214,575 | $1.91M | 0.31% |
| Yelin Lapidot Holdings Management Ltd. | 809,717 | $1.27M | 0.21% |
| Two Sigma Securities, LLC | 39,939 | $62.7K | 0.00% |
| HRT Financial LP | 13,579 | $21.0K | 0.00% |
| Millennium Management LLC | 10,565 | $16.6K | 0.00% |
| UBS Group AG | 2,288 | $3.59K | 0.00% |
Sold out (6)
Institutions that held Chemomab Therapeutics Ltd. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Citadel Advisors LLC | 62,402 | $57.4K |
| Two Sigma Investments, LP | 24,394 | $22.3K |
| Two Sigma Advisers, LP | 18,100 | $16.5K |
| Geode Capital Management, LLC | 11,737 | $10.8K |
| Advisor Group Holdings, Inc. | 1,000 | $912 |
| Qube Research & Technologies Ltd | 44 | $40 |